These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25510697)

  • 21. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
    Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low expression of miR-449 in gynecologic clear cell carcinoma.
    Jang SG; Yoo CW; Park SY; Kang S; Kim HK
    Int J Gynecol Cancer; 2014 Nov; 24(9):1558-63. PubMed ID: 25238166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC; Chow AS; Au JS
    Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.
    Yanaihara N; Noguchi Y; Saito M; Takenaka M; Takakura S; Yamada K; Okamoto A
    PLoS One; 2016; 11(9):e0162584. PubMed ID: 27612152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differential expression of hsa-miR-126 and hsa-miR-518b in esophageal squamous carcinoma].
    Cai H; Wang JS; Zhang MX; Duan XY; Ma RQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):23-7. PubMed ID: 21269950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions.
    Xu Y; Zhang X; Pu S; Wu J; Lv Y; Du D
    Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):942-9. PubMed ID: 25274330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Elevated levels of dendritic cell-correlated miRNAs in ascites and sera of patients with ovarian cancer].
    Wu X; Zhi X; Liu M; Xie J; Zhao S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):383-6. PubMed ID: 25744846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
    Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X
    Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
    Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M
    Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.
    Lopacinska-Jørgensen J; Oliveira DVNP; Novotny Wayne; Høgdall CK; Høgdall EV
    PLoS One; 2021; 16(7):e0255142. PubMed ID: 34320033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
    Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
    Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and its clinical significance of hsa-miR-155 in serum of endometrial cancer].
    Tan ZQ; Liu FX; Tang HL; Su Q
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):772-4. PubMed ID: 21176560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
    Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
    Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
    BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential microRNA expression in the serum of patients with nephrotic syndrome and clinical correlation analysis.
    Teng J; Sun F; Yu PF; Li JX; Yuan D; Chang J; Lin SH
    Int J Clin Exp Pathol; 2015; 8(6):7282-6. PubMed ID: 26261628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarray analysis of differentially expressed microRNAs in allergic rhinitis.
    Shaoqing Y; Ruxin Z; Guojun L; Zhiqiang Y; Hua H; Shudong Y; Jie Z
    Am J Rhinol Allergy; 2011; 25(6):e242-6. PubMed ID: 22185732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.